Curis (CRIS)

• Market cap: $11.7M
• 1 day: -0.3%
• 5 days: -2.37%
• 1 month: -10.1%
• 3 months: -39.06%
• 6 months: -46.9%
• Year to date: -7.63%
• 1 year: -72.4%
• 5 years: -99.56%
• 10 years: -99.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 33